Market Research

Clinical Trial Patient Recruitment Services Market Forecasts to 2030 – Global Analysis By Therapeutic Areas (Central Nervous System, Anti-Infective, Endocrine, Respiratory Diseases, Cardiovascular, Pain & Anesthesia, Oncology, Dermatological Disorders , H

Best Price Guarantee Length Publisher Published Date SKU
from $4,150 200 Pages Stratistics Market Research Consulting November, 2023 SMR18332721
Best Price Guarantee
Price from $4,150
Length 200 Pages
Publisher Stratistics Market Research Consulting
Published Date November, 2023
SKU SMR18332721

Clinical Trial Patient Recruitment Services Market Forecasts to 2030 – Global Analysis By Therapeutic Areas (Central Nervous System, Anti-Infective, Endocrine, Respiratory Diseases, Cardiovascular, Pain & Anesthesia, Oncology, Dermatological Disorders, Hematological Disorders and Other Therapeutic Areas), Phase (Phase I, Phase II, Phase Ill and Phase IV), Age Group and By Geography


According to Stratistics MRC, the Global Clinical Trial Patient Recruitment Services Market is accounted for $1.19 billion in 2023 and is expected to reach $2.55 billion by 2030 growing at a CAGR of 11.5% during the forecast period. Services specifically designed to assist researchers and pharmaceutical companies in finding and recruiting qualified subjects for their clinical trials are known as clinical trial patient recruitment services. In order to help clinical trials get underway more quickly, patient recruitment services can speed up the process of identifying and enrolling eligible participants. For researchers to better understand a treatment's efficacy and safety across a range of demographic groups it is imperative to have a more diverse and representative patient population, which is a factor that patient recruitment services can help ensure.

According to ClinicalTrial.gov, there has been a 49.2% rise in clinical trials over the past 5 years.

Market Dynamics:

Driver:

Rising Number of Clinical Trials

One major factor propelling the market for clinical trial patient recruitment services is the rise in the number of clinical trials. The ongoing developments in pharmaceutical research, medical research, and the search for novel therapies and treatments are the main drivers of this rise in clinical trial activity. Specialized patient recruitment services are in increasing demand as pharmaceutical and biotechnology companies, academic institutions, and research organizations step up their efforts to introduce novel drugs, medical devices, and therapies to the market.

Restraint:

Budgetary restrictions

Budgetary restrictions are a typical problem for research institutions and pharmaceutical companies. Although patient recruitment services are essential to the smooth running of trials, their costs can be a significant factor. These services usually come with a number of costs, such as hiring staff, using cutting-edge technologies, advertising, and outreach programs to find and connect possible trial participants. Furthermore, providers of patient recruitment services may feel pressured to offer competitive pricing in a market that is fiercely competitive, which could affect their profit margins and capacity to make investments in cutting-edge tactics and technologies. Therefore, it is a significant barrier to market growth.

Opportunity:

Advanced technologies

Numerous recruitment agencies use advanced technologies, like artificial intelligence and data analytics, to improve participant identification accuracy and efficiency. Data analytics is being used by patient recruitment services in increasing numbers to quickly and accurately identify possible trial participants by sorting through large datasets. This analytical method makes it possible to identify people who fit the precise requirements of each clinical trial by methodically evaluating a variety of patient characteristics and medical histories. These factors propel market demand.

Threat:

Regulatory challenges

The regulatory landscape for clinical trials is complex and subject to constant change. Recruitment agencies may find it difficult to remain compliant with changing regulations, such as those pertaining to data protection and informed consent. Additionally, there are stringent regulations pertaining to patient privacy, data protection, and informed consent that apply to clinical trials. Patient recruitment services may find it difficult to comply with regulatory bodies' strict guidelines when it comes to gathering, storing, and sharing patient data. These factors hamper market expansion.

Covid-19 Impact

The COVID-19 pandemic has had a significant impact on the clinical trial patient recruitment services market. Numerous ongoing clinical trials were disrupted by the pandemic, which had a significant negative impact on trial enrolment and patient recruitment. Phase-outs, travel bans, and restricted access to medical facilities made it difficult to carry out trials as scheduled. In order to improve remote monitoring capabilities and collect real-time patient data while minimizing the need for in-person visits, patient recruitment services worked with tech companies.

The respiratory diseases segment is expected to be the largest during the forecast period

The respiratory diseases segment is estimated to hold the largest share. The Clinical Trial Patient Recruitment Services' respiratory diseases section focuses on a particular field of clinical research that is committed to the creation of cures and treatments for a range of respiratory ailments. For the purpose of assessing the safety and effectiveness of novel medications, inhalers, biologics, and medical devices intended to enhance lung function, reduce symptoms, or stop exacerbations, clinical trials are crucial.

The phase II segment is expected to have the highest CAGR during the forecast period

The phase II segment is anticipated to have lucrative growth during the forecast period. In the clinical research spectrum, Phase II clinical trials are a crucial stage that comes after Phase I trials and before Phase III trials. The main goals of Phase II trials are to evaluate a new treatment or medication's safety and effectiveness in a larger patient population. The Phase II segment recruitment services are responsible for identifying and enrolling eligible participants who meet the precise requirements specified in the trial protocol.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the large number of active clinical trials in the region, the market is anticipated to increase rapidly. Significant R&D expenditures and government funding for clinical studies also drive the industry. The industry's growth in North America has been facilitated by the existence of top contract research organizations (CROs) that provide extensive support services, such as patient recruiting, and by the active involvement of global pharmaceutical and biopharmaceutical corporations.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period. There is an increase in off shoring clinical trials to emerging economies like India, Japan, South Korea, and others. This is because there is a large patient pool and trials are inexpensive, which further promotes regional expansion. The availability of qualified medical professionals, a robust hospital network, and developed clinical research infrastructure are all contributing to the Asia-Pacific market's expansion.

Key players in the market

Some of the key players in the Clinical Trial Patient Recruitment Services Market include Clinical Site Services, Clara Health, Worldwide Clinical Trials, Clariness, Veristat, PPD Inc, BBK Worldwide, Elligo Health Research, Antidote Technologies, Inc., IQVIA, Matthews Media Group Inc., Conduent, Inc., Biorasi, LLC, Trialfacts and Syneos Health.

Key Developments:

In August 2023, Worldwide Clinical partners with Cybin for psychedelic-based treatments. Cybin, a biopharma developing psychedelic-based treatment options for mental health issues.

In December 2021, worldwide clinical Trials and WCG partner to accelerate and streamline global safety event distribution. Worldwide offers a comprehensive suite of pharmacovigilance capabilities, including a regulatory intelligence database that is unique to the company and enhanced by WCG’s proprietary Safety Vigilance portal.

Therapeutic Areas Covered:
• Central Nervous System
• Anti-Infective
• Endocrine
• Respiratory Diseases
• Cardiovascular
• Pain & Anaesthesia
• Oncology
• Dermatological Disorders
• Haematological Disorders
• Other Therapeutic Areas

Phases Covered:
• Phase I
• Phase II
• Phase Ill
• Phase IV

Age Groups Covered:
• Child
• Adult

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Clinical Trial Patient Recruitment Services Market, By Therapeutic Areas
5.1 Introduction
5.2 Central Nervous System
5.3 Anti-Infective
5.4 Endocrine
5.5 Respiratory Diseases
5.6 Cardiovascular
5.7 Pain & Anesthesia
5.8 Oncology
5.9 Dermatological Disorders
5.10 Hematological Disorders
5.11 Other Therapeutic Areas
6 Global Clinical Trial Patient Recruitment Services Market, By Phase
6.1 Introduction
6.2 Phase I
6.3 Phase II
6.4 Phase Ill
6.5 Phase IV
7 Global Clinical Trial Patient Recruitment Services Market, By Age Group
7.1 Introduction
7.2 Child
7.3 Adult
8 Global Clinical Trial Patient Recruitment Services Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Clinical Site Services
10.2 Clara Health
10.3 Worldwide Clinical Trials
10.4 Clariness
10.5 Veristat
10.6 PPD Inc
10.7 BBK Worldwide
10.8 Elligo Health Research
10.9 Antidote Technologies, Inc.
10.10 IQVIA
10.11 Matthews Media Group Inc.
10.12 Conduent, Inc.
10.13 Biorasi, LLC
10.14 Trialfacts
10.15 Syneos Health
List of Tables
Table 1 Global Clinical Trial Patient Recruitment Services Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 3 Global Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 4 Global Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 5 Global Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 6 Global Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 7 Global Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 8 Global Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 9 Global Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 10 Global Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 11 Global Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 12 Global Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 13 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 14 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 15 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 16 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 17 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 18 Global Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 19 Global Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 20 Global Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 21 North America Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 22 North America Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 23 North America Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 24 North America Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 25 North America Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 26 North America Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 27 North America Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 28 North America Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 29 North America Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 30 North America Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 31 North America Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 32 North America Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 33 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 34 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 35 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 36 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 37 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 38 North America Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 39 North America Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 40 North America Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 41 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 42 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 43 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 44 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 45 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 46 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 47 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 48 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 49 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 50 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 51 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 52 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 53 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 54 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 55 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 56 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 57 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 58 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 59 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 60 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 61 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 62 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 63 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 64 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 65 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 66 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 67 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 68 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 69 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 70 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 71 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 72 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 73 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 74 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 75 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 76 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 77 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 78 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 79 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 80 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 81 South America Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 82 South America Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 83 South America Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 84 South America Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 85 South America Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 86 South America Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 87 South America Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 88 South America Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 89 South America Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 90 South America Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 91 South America Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 92 South America Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 93 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 94 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 95 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 96 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 97 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 98 South America Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 99 South America Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 100 South America Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 101 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 102 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 103 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 104 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 105 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 106 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 107 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 108 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 109 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 110 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 111 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 112 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 113 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 114 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 115 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 116 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 117 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 118 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 119 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 120 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)

$4,150
$7,500

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings